ArticleLiver cancer2024

Incidence of Hyper Progressive Disease in Combination Immunotherapy and Anti-Programmed Cell Death Protein 1/Programmed Death-Ligand 1 Monotherapy for Unresectable Hepatocellular Carcinoma.

Tomoko Aoki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.